Aging and cancer: molecular facts and awareness for Turkey

Two important subjects concerning extension of the human life-span are biological aging processes and their relationship to diseases, and especially to the formation of cancer. It is clear that an aging population poses some challenges for developing countries. We set out to show the demographic structure of Turkey and to discuss the feasibility of decreasing the prevalence of cancer. We overviewed the literature on the relationship between biological aging and cancer formation, the environmental causes of cancer, and age-related characteristics of cancer in the elderly. In addition, some statistical data on the changing demography of Turkey were reviewed. It is seen that some predictions and preliminary preparations should be taken. However, in order to take precautions, first of all there must be a holistic approach from the causes to the consequences.

Anahtar Kelimeler:

Biological aging, cancer, molecular mechanisms, environmental factors, age-related cancer characteristics, epidemiology, Turkey

Aging and cancer: molecular facts and awareness for Turkey

Keywords:

Biological aging, cancer, molecular mechanisms, environmental factors, age-related cancer characteristics, epidemiology, Turkey,

PDF

___

Adams JM, White M (2004). Biological aging. Eur J Pub Health 14: 331–334.
Anisimov VN (2009). Carcinogenesis and aging 20 years after: escaping horizon. Mech Ageing Dev 130: 105–121.
Anisimov VN (2001). New horizons in biogerontology: from molecules to humans. Mech Ageing Dev 122: 1359–1360.
Bassi PF, Sacco E (2009). Cancer and aging: the molecular pathways. Urol Oncol 27: 620–627.
Campisi J, Andersen JK, Kapahi P, Melov S (2011). Cellular senescence: a link between cancer and age related degenerative disease. Semin Cancer Biol 21: 354–359.
Carnes BA, Staats DO, Sonntag WE (2008). Does senescence give rise to disease? Mech Ageing Dev 129: 693–699.
Castle SC, Uyemura K, Fulop T, Makinodan T (2007). Host resistance and immune responses in advanced age. Clin Geriatr Med 23: 463–479.
Clough-Gorr KM, Silliman RA (2012). The epidemiology of cancer and aging. In: Naeim A, Reuben D, Ganz P, editors. Management of Cancer in the Older Patient. Philadelphia, PA, USA: Elsevier, pp. 3–17.
Eser S, Karakılınç, Özdemir R (2010a). Decline in the age specific cancer incidence rates among the elderly in Turkey (İzmir and Antalya): is it a cohort effect, survival bias or an indicator of lack of accesibility to health care for older adults? Türkiye Halk Sağ Der 8: 153–164 (in Turkish with English abstract).
Eser S, Özdemir R (2012). Bladder cancer epidemiology in the world and in Tukey. Üroonkoloji Bült 11: 1–9 (in Turkish with English abstract).
Eser S, Yakut C, Özdemir R, Karakılınç H, Özalan S, Marshall SF, Karaoğlanoğlu O, Anbarcıoglu Z, Ucuncu N, Akın U et al. (2010b). Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev 11: 1731– 1739.
Fontana L (2009). Modulating human aging and age associated diseases. Biochim Biophys Acta 1790: 1133–1138.
Franceschi S, Wild CP (2013). Meeting the global demands of epidemiologic transition - the indispensable role of cancer prevention. Mol Oncol 7: 1–13.
Gonzales C, Riboli E (2010). Diet and cancer prevention: contributions from the European Prospective Investigation into cancer and nutrition (EPIC) study. Eur J Cancer 46: 2555– 2562.
Harman D (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298–300.
Hayflick L (2000). Future of aging. Nature 408: 267–269.
Heemst DV (2009). Biology of cancer and aging. Eur J Cancer 45: 414–415.
Hipkiss AR (2007). Biological aspects of ageing. Psychiatry 6: 476– 479.
Hodek P, Krizkova J, Burdova K, Sulc M, Kizek J, Hudecek,J, Stiborova M (2009). Chemopreventive compounds--view from the other side. Chem Biol Interact 180: 1–9.
Hornsby PJ (2011). Cellular aging and cancer. Crit Rev Oncol Hematol 79: 189–195.
Kennedy SR, Loeb LA, Herr AJ (2012). Somatic mutations in aging, cancer and neurodegeneration. Mech Ageing Dev 133: 118– 126.
Kirkwood TBL, Austad SN (2000). Why do we age? Nature 408: 233–238.
Leibovici J, Itzhaki O, Kaptzan T, Skutelsky E, Sinai J, Michhowitz M, Asfur R, Siegal A, Huszar M, Schiby G (2009). Designing aging conditions in tumor microenvironment--a new possible modality for cancer treatment. Mech Ageing Dev 130: 76–85.
Longo VD, Fontana L (2009). Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 31: 89–96.
Maslov AY, Vijg J (2009). Genome instability, cancer and aging. Biochim Biophys Acta 1790: 963–969.
McGuinn LA, Ghazarian AA, Ellison GL, Harvey CE, Kaefer CM, Reid BC (2012). Cancer and environment: definitions and misconceptions. Environ Res 112: 230–234.
Mena S, Ortega A, Estrela JM (2009). Oxidative stress in environmental induced carcinogenesis. Mutat Res 674: 36–44.
Migliore L, Coppede F (2009). Environmental induced oxidative stress in neurodegenerative disorders and aging. Mutat Res 674: 73–84.
OECD/European Union (2010). Health at a Glance: Europe 2010. Paris, France: OECD Publishing.
Okada F, Kobayashi H (2012). The influence of aging and cellular senescence on metastasis. In: Lyden D, Welch DR, Psaila B, editors. Cancer Metastasis: Biological Basis and Therapeutics. Cambridge, UK: Cambridge University Press, pp. 105–116.
Sicora E, Arendt T, Bennet M, Narita M (2011). Impact of cellular senescence signature on ageing research. Ageing Res Rev 10: 146–152.
Stillman FC, Kaufman MR, Kibria N, Eser S, Spires M, Pustu Y (2012). Cancer registries in four provinces in Turkey: a case study. Global Health 8: 34.
Vasto S, Carruba G, Lio D, Colonna-Romano G, Di Bona D, Candore G, Caroso C (2009). Inflammation, ageing and cancer. Mech Ageing Dev 130: 40–45.
Sander M, Avlund K, Lauritzen M, Gottlieb T, Halliwell B, Stevnsner T, Wewer U, Bohr VA (2008). Aging-from molecules to populations. Mech Ageing Dev 129: 614–623.
Yashin A, Ukraintseva SV, Akushevich IV, Arbeev KG, Kulminski A, Akushevich L (2009). Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. Mech Ageing Dev 130: 98–104.
Yilmaz HH, Yazıhan N, Tunca D, Sevinç A, Olcayto EO, Ozgul N, Tuncer M (2011). Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol 41: 10–16.
Yi J, Luo J (2010). SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 1804: 1684–1689.